N
Niteesh K. Choudhry
Researcher at Brigham and Women's Hospital
Publications - 330
Citations - 17602
Niteesh K. Choudhry is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Health care & Randomized controlled trial. The author has an hindex of 64, co-authored 308 publications receiving 15522 citations. Previous affiliations of Niteesh K. Choudhry include Mount Sinai Hospital & Harvard University.
Papers
More filters
Journal ArticleDOI
Systematic Review: The Relationship between Clinical Experience and Quality of Health Care
TL;DR: The robustness of the relationship between clinical experience and quality of care is assessed by systematically reviewing empirical studies to assess the effects of experience on the quality of medical care.
Journal ArticleDOI
Online Social Networking by Patients with Diabetes: A Qualitative Evaluation of Communication with Facebook
TL;DR: Facebook provides a forum for reporting personal experiences, asking questions, and receiving direct feedback for people living with diabetes, however, promotional activity and personal data collection are also common, with no accountability or checks for authenticity.
Journal ArticleDOI
Full coverage for preventive medications after myocardial infarction
Niteesh K. Choudhry,Jerry Avorn,Robert J. Glynn,Elliott M. Antman,Sebastian Schneeweiss,Michele Toscano,Lonny Reisman,Joaquim Fernandes,Claire M. Spettell,Joy L. Lee,Raisa Levin,Troyen A. Brennan,William H. Shrank +12 more
TL;DR: In this paper, patients discharged after myocardial infarction were randomly assigned their insurance-plan sponsors to full prescription coverage (1494 plan sponsors with 2845 patients) or usual prescription coverage for all statins, beta-blockers, angiotensin-converting-enzyme inhibitors, or angiotENSin-receptor blockers.
Journal ArticleDOI
Relationships between authors of clinical practice guidelines and the pharmaceutical industry.
TL;DR: There appears to be considerable interaction between CPG authors and the pharmaceutical industry, and the need for appropriate disclosure of financial conflicts of interest for authors of CPGs and a formal process for discussing these conflicts prior to CPG development is highlighted.
Journal ArticleDOI
Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease: A Systematic Review and Meta-analysis
Aaron S. Kesselheim,Alexander S. Misono,Joy L. Lee,Margaret Stedman,M. Alan Brookhart,Niteesh K. Choudhry,William H. Shrank +6 more
TL;DR: Clinical evidence does not support the notion that brand-name drugs used in cardiovascular disease are superior to generic drugs, and a substantial number of editorials counsel against the interchangeability of generic drugs.